PR
ProKidney Corp.
PROK · NASDAQ
$1.78 -5.08% (-$0.10)
1M +10.56%
Market Cap $263.0M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$2.55
43.7% upside
Trenutna cena
$1.78
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PROK trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 321.51x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 252.57%
FCF margin 19,527.40%
Net margin 10,599.80%
Quality
0 /100
Poor ROIC 68.08%
Asset turnover 0.00x
ROA 34.82%
Debt
43 /100
Moderate Current ratio 8.36x
Int. coverage -8,776.74x
Debt/Equity N/A
Stability
28 /100
Unstable Beta 1.75x
Profitable years 0
EPS volatility 38.96%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PROK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bruce Culleton
Employees
231
Headquarters
Winston-Salem
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report